Altis Labs Logo

About us

Altis Labs is the AI-powered computational imaging company advancing precision medicine.

We believe that medical imaging, making up 90% of all healthcare data, is the richest source of clinical insight but is vastly underutilized. Trained on the world’s largest cancer imaging database, our deep learning models predict patient outcomes to measure treatment effect more accurately.

Leading biopharmaceutical companies use our AI-powered imaging biomarker platform, Nota, to analyze clinical trial imaging data in a more meaningful way, allowing them to accelerate and de-risk all stages of clinical development.

Based in Toronto, a city recognized for its deep learning research and renowned medical institutions, our multi-disciplinary team is on a mission to guide personalized treatment and help patients get access to the most effective therapies sooner.

Program engagement

Altis Labs Inc.

Leadership

Felix Baldauf-Lenschen

Co-Founder and CEO

Sally Daub

Co-Founder and President

Duoaud Shah

VP of Clinical Partnerships

Reid Lobson

Chief of Staff

Status

Intellectual Property

In Market

Sector

Subsector

Synapse Life Science Pitch Competition applications open. Apply by November 10, 2024

Applications for the 2025 Synapse Competition are open!

The Synapse Life Science Competition combines the ideas and research of life science innovators with the intellect and strategy of students. Finalists receive training, mentorship, a $2,000 grant and a chance to pitch and compete for BIG cash prizes!

Applications close on November 10, 2024.